Mays Cancer Center, UT Health San Antonio
San Antonio, Texas 78229-3900
5 studies enrolling now · 22 studies all time
What they study most
Anxiety, Brain Tumor, Breast Cancer, Breast Cancer Metastatic, COVID-19 Vaccine, Cancer, Cancer Survivorship, Cancer of Lung, DNA Damage Repair Deficiency, Gastric Cancer, Glioblastoma, Hepatocellular Carcinoma
Studies at this site
- Impact of Ketogenic Diet on Tumor Microenvironment in Patients With Breast Cancer — Recruiting now
- Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA) — Recruiting now
- Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy — Recruiting now
- Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma — Recruiting now
- A Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant — Completed
- Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer — Stopped early
- Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain — Starting soon
- Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer) — Withdrawn before enrolling
- Safety of SP-420 in the Treatment of Transfusional Iron Overload — Stopped early
- Radiation Oncology Patient Medical Physics Intervention Study — Completed
- Vertebral Marrow Attention Trial (VMAT) — Completed
- Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0 — Completed
- 4D CBCT and Intrafractional Imaging for the Determination of the Most Representative 4D Simulation Planning Technique for Lung SBRT Technique Patients — Completed
- Clinical Trial of Roflumilast Added to Standard Chemoimmunotherapy — Withdrawn before enrolling
- Study of Roflumilast in Combination With Standard Chemotherapy for High-risk Diffuse Large B-cell Lymphoma — Completed
- A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD) — Completed
- Dose Escalation Trial of Bexmarilimab (FP-1305) Plus Pembrolizumab in Non-Small Cell Lung Cancer — Withdrawn before enrolling
- Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects — Completed
- Imipramine on ER+ve and Triple Negative Breast Cancer — Completed
- Host Immune Response to Novel RNA COVID-19 Vaccination — Completed
- Taking Time to Connect: A Study of Programs for Hispanic Mothers Diagnosed With Cancer and Their Children — Completed
- Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis — Stopped early